These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15958049)

  • 21. Understanding epoetin use: databases or clinical trials?
    Roger SD
    Nephrology (Carlton); 2007 Apr; 12(2):118-9. PubMed ID: 17371331
    [No Abstract]   [Full Text] [Related]  

  • 22. [A case of the good effect of low doses of erythropoietin].
    Shostka GD; Dobronravov VA; Vasil'ev AN
    Urol Nefrol (Mosk); 1991; (5):74-5. PubMed ID: 1755131
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-acting erythropoietin: clinical studies and potential uses in neonates.
    Ohls RK; Dai A
    Clin Perinatol; 2004 Mar; 31(1):77-89. PubMed ID: 15183658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of correcting anemia with recombinant erythropoietin on the central hemodynamic indices of patients on regular hemodialysis].
    Ermolenko VM; Khvoĭnitskiĭ VA; Suprun EK; Tsukerman LI; Pokrovskiĭ IuA
    Ter Arkh; 1992; 64(7):86-8. PubMed ID: 1440377
    [No Abstract]   [Full Text] [Related]  

  • 25. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis].
    Martínez Castelao A; Reyes A; Valdés F; Otero A; López de Novales E; Pallardó L; Tabernero JM; Hernández Jaras J; Lladós F
    Nefrologia; 2003; 23(2):114-24. PubMed ID: 12778875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of the anaemia of chronic renal failure with recombinant erythropoietin.
    Adamson JW; Eschbach JW
    Q J Med; 1989 Dec; 73(272):1093-101. PubMed ID: 2694210
    [No Abstract]   [Full Text] [Related]  

  • 27. [Methoxy polyethylene glycol-epoetin beta (Mircera) in the treatment of a patient with chronic kidney disease presenting late-onset hypersensitivity to other epoetins].
    Dávila Fajardo CL; Peña Ortega M; Cabeza Barrera J; Prados Garrido MD
    Nefrologia; 2010; 30(3):372-3. PubMed ID: 20514110
    [No Abstract]   [Full Text] [Related]  

  • 28. [The pharmacokinetics of recombinant human erythropoietin].
    Siniukhin VN; Stetsiuk EA; Lovchinskiĭ EV; Lebedev SV; Iarmolinskiĭ IS; Liakhov VV
    Ter Arkh; 1994; 66(8):60-2. PubMed ID: 7985158
    [No Abstract]   [Full Text] [Related]  

  • 29. Erythropoietin therapy in patients with chronic renal failure.
    Pinevich AJ; Petersen J
    West J Med; 1992 Aug; 157(2):154-7. PubMed ID: 1441466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful re-introduction of recombinant human erythropoietin following antibody induced pure red cell aplasia.
    Summers SA; Matijevic A; Almond MK
    Nephrol Dial Transplant; 2004 Aug; 19(8):2137-9. PubMed ID: 15252175
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cutaneous reactions to treatment with recombinant human erythropoietin].
    Schröder-Kolb B
    Derm Beruf Umwelt; 1990; 38(1):12-3. PubMed ID: 2139602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of subcutaneous erythropoietin in CAPD patients.
    Piraino B; Johnston JR
    Clin Nephrol; 1990 Apr; 33(4):200-2. PubMed ID: 2350907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
    Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S
    Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epoetin-associated pure red cell aplasia in patients with chronic kidney disease: solving the mystery.
    Boven K; Knight J; Bader F; Rossert J; Eckardt KU; Casadevall N
    Nephrol Dial Transplant; 2005 May; 20 Suppl 3():iii33-40. PubMed ID: 15824129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of renal anemia using synthetic human erythropoietin].
    Blumberg A; Zehnder C
    Ther Umsch; 1988 Dec; 45(12):895-9. PubMed ID: 3065970
    [No Abstract]   [Full Text] [Related]  

  • 36. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
    Sobota JT
    Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519
    [No Abstract]   [Full Text] [Related]  

  • 37. [Diagnosis and treatment of pure red-cell aplasia induced by erythropoiesis stimulating agents].
    Rossert J; Casadevall N
    Nephrol Ther; 2006 Sep; 2 Suppl 4():S283-6. PubMed ID: 17373271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythropoietin for anemia.
    Med Lett Drugs Ther; 1989 Sep; 31(801):85-6. PubMed ID: 2671624
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of recombinant human erythropoietin on hematopoietic progenitors of chronic hemodialysis patients in vitro and in vivo.
    Hino M; Miyazono K; Urabe A; Takaku F
    Int J Cell Cloning; 1989 Jul; 7(4):257-63. PubMed ID: 2768843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Erythropoietin: from established therapeutic procedures in renal anemia to future areas of use].
    Marsen TA; Pollok M; Baldamus CA
    Med Klin (Munich); 1992 Apr; 87(4):207-14. PubMed ID: 1579099
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.